Courier Therapeutics, Inc. logo

Courier Therapeutics, Inc.

Courier Therapeutics is a biotechnology startup with a cytotoxic-lymphocyte targeting therapy platform, with a focus on making cancer-immunotherapy safer and more efficacious. Courier's first application of this targeting technology technology, CT101, is a first-in-class IL2R agonist which specifically activates the NK and CD8 T cells against cancer.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.couriertherapeutics.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3737 Buffalo Speedway Suite 1750, 77098
Houston
United States
2450 Holcombe Blvd Suite J, 77021
Houston
United States
Email
Contact Number